AbbVie Inc (ABBV) Stock Price Today
Aura AI Summary
Key Stats
- $449.91BMARKET_CAP
- -VOLUME
- HealthSECTOR
- $261.07FIFTY_TWO_WEEK_HIGH
- $184.85FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $513.38BENTERPRISE_VALUE
- 2.72%DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track AbbVie Inc (ABBV) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbbVie Inc has traded between a low of $184.85 and a high of $261.07, highlighting its annual price range. Buy and sell AbbVie Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Most Recent News
Wedbush celebrates 18 years with Cboe, highlighting market innovation and expanding digital asset trading.
Wedbush rang the closing bell at Cboe Global Markets to mark 18 years as a Cboe member, celebrating a partnership focused on innovation and market integrity. Since joining in 2008, Wedbush has supported the evolution of financial markets through new ...

Lawsuit challenges government-led censorship of Covid vaccine injury discussions on social media.
The New Civil Liberties Alliance (NCLA) filed an appeal to revive a lawsuit against the Biden Administration and private companies for censoring social media posts by individuals injured by Covid vaccines. Plaintiffs, including vaccine-injured indivi...

Global golf simulators market to reach $5.5B by 2035 with 8.6% CAGR, driven by tech advances and rising home use
The global golf simulators market, valued at $2.4 billion in 2025, is projected to grow to $5.5 billion by 2035 at an 8.6% CAGR. Growth is fueled by technological improvements, increased commercial and residential use, and rising demand for indoor go...
